Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Valganciclovir 450 mg Tablets in Healthy Adults
NCT02297854Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jul 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of valganciclovir in cytomegalovirus infection (CMV) (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area Under Curve. Started Jul 2011; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT02297854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297854.